• Explore /
  • Poster
  • / Impact of baseline hepatitis B viremia and management on outcomes in patients (Pts) with advanced hepatocellular carcinoma (HCC) and elevated alpha-fetoprotein (AFP): Outcomes from REACH-2.

Impact of baseline hepatitis B viremia and management on outcomes in patients (Pts) with advanced hepatocellular carcinoma (HCC) and elevated alpha-fetoprotein (AFP): Outcomes from REACH-2.

Abstract Poster

Authors

Peter Robert Galle

Peter R. Galle

University Medical Center, Mainz, Germany

Peter R. Galle , Masatoshi Kudo , Josep M. Llovet , Richard S. Finn , Mark Karwal , Denis Pezet , Tae-You Kim , Tsai-Sheng Yang , Vittorina Zagonel , Jiri Tomasek , Jean Marc Phelip , Yann Touchefeu , Su-Jin Koh , Guido Stirnimann , Chunxiao Wang , Kenyon Ogburn , Paolo Abada , Ryan C. Widau , Andrew X. Zhu

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Hepatobiliary Cancer, Neuroendocrine/Carcinoid, Pancreatic Cancer, and Small Bowel Cancer

Track

Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Pancreatic Cancer,Small Bowel Cancer,Other GI Cancer

Sub Track

Tumor Biology, Biomarkers, and Pathology

Clinical Trial Registration Number

NCT02435433

Citation

J Clin Oncol 38, 2020 (suppl 4; abstr 569)

Abstract #

569

Poster Bd #

E8

Abstract Disclosures

Similar Posters

First Author: Masatoshi Kudo

First Author: Josep M Llovet

First Author: Richard S. Finn

First Author: Maria Reig